107 related articles for article (PubMed ID: 7783136)
1. Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sites.
Langlois M; Brémont B; Shen S; Poncet A; Andrieux J; Sicsic S; Serraz I; Mathé-Allainmat M; Renard P; Delagrange P
J Med Chem; 1995 Jun; 38(12):2050-60. PubMed ID: 7783136
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibitory effects of melatonin analogs and three naphthalenic ligands on 2-[125I]iodomelatonin binding to chicken tissues.
Pang CS; Tang PL; Song Y; Pang SF; Ng KW; Guardiola-Lemaitre B; Delagrange P; Brown GM
J Pineal Res; 1997 Oct; 23(3):148-55. PubMed ID: 9406986
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.
Mathé-Allainmat M; Le Gall M; Jellimann C; Andrieux J; Langlois M
Bioorg Med Chem; 1999 Dec; 7(12):2945-52. PubMed ID: 10658600
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the chicken brain melatonin-binding protein using iodinated and tritiated ligands.
Kennaway DJ; Hugel HM; Rowe SA
J Pineal Res; 1994 Oct; 17(3):137-48. PubMed ID: 7897586
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
Depreux P; Lesieur D; Mansour HA; Morgan P; Howell HE; Renard P; Caignard DH; Pfeiffer B; Delagrange P; Guardiola B
J Med Chem; 1994 Sep; 37(20):3231-9. PubMed ID: 7932550
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
Leclerc V; Fourmaintraux E; Depreux P; Lesieur D; Morgan P; Howell HE; Renard P; Caignard DH; Pfeiffer B; Delagrange P; Guardiola-Lemaître B; Andrieux J
Bioorg Med Chem; 1998 Oct; 6(10):1875-87. PubMed ID: 9839017
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT(4) receptor ligands.
Diouf O; Depreux P; Chavatte P; Poupaert JH
Eur J Med Chem; 2000; 35(7-8):699-706. PubMed ID: 10960185
[TBL] [Abstract][Full Text] [Related]
10. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites.
Molinari EJ; North PC; Dubocovich ML
Eur J Pharmacol; 1996 Apr; 301(1-3):159-68. PubMed ID: 8773460
[TBL] [Abstract][Full Text] [Related]
11. 2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution.
Duncan MJ; Takahashi JS; Dubocovich ML
Endocrinology; 1988 May; 122(5):1825-33. PubMed ID: 2834175
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
[TBL] [Abstract][Full Text] [Related]
13. Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina.
Dubocovich ML; Takahashi JS
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3916-20. PubMed ID: 3035559
[TBL] [Abstract][Full Text] [Related]
14. Characterization of melatonin binding sites in chicken and human intestines.
Pontoire C; Bernard M; Silvain C; Collin JP; Voisin P
Eur J Pharmacol; 1993 Oct; 247(2):111-8. PubMed ID: 8281999
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
Descamps-François C; Yous S; Chavatte P; Audinot V; Bonnaud A; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
J Med Chem; 2003 Mar; 46(7):1127-9. PubMed ID: 12646022
[TBL] [Abstract][Full Text] [Related]
16. 2-[125I]iodomelatonin labels sites with identical pharmacological characteristics in chicken brain and chicken retina.
Dubocovich ML; Shankar G; Mickel M
Eur J Pharmacol; 1989 Mar; 162(2):289-99. PubMed ID: 2542059
[TBL] [Abstract][Full Text] [Related]
17. [New naphthalenic ligands of melatoninergic receptors].
Adam G; Guardiola-Lemaitre B; Yous S; Lesieur D; Morgan P; Howell HE; Andrieux J; Caignard DH; Pfeiffer B; Renard P
J Pharm Belg; 1992; 47(4):374-80. PubMed ID: 1328595
[TBL] [Abstract][Full Text] [Related]
18. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
[TBL] [Abstract][Full Text] [Related]
19. 2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents.
Copinga S; Tepper PG; Grol CJ; Horn AS; Dubocovich ML
J Med Chem; 1993 Oct; 36(20):2891-8. PubMed ID: 8411005
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new arylalkoxy amido derivatives as melatoninergic ligands.
Pégurier C; Morellato L; Chahed E; Andrieux J; Nicolas JP; Boutin JA; Bennejean C; Delagrange P; Langlois M; Mathé-Allainmat M
Bioorg Med Chem; 2003 Mar; 11(5):789-800. PubMed ID: 12538010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
